FOSPHENYTOIN TO POTENTIALLY INDUCE CLEARANCE OF TACROLIMUS LEVEL SECONDARY TO NIRMATRELVIR/RITONAVIR

被引：0
|
作者：
Schwarz, Jacob [1 ]
Robinson, John [2 ]
Rusk, Ann [3 ]
Heilman, Raymond [1 ]
Cartin-Ceba, Rodrigo [1 ]
机构：
[1] Mayo Clin, Phoenix, AZ USA
[2] Kingman Reg Med Ctr, Kingman, AZ USA
[3] Mayo Clin, Coll Med, Phoenix, AZ USA
来源：
CRITICAL CARE MEDICINE | 2024年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
941
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Successful Use of Phenytoin/ Fosphenytoin in a Pediatric Transplant Recipient with Nimatrelvir/ Ritonavir Induced Tacrolimus Toxicity
    Hewlett, J.
    Goka, S.
    Nwaogazie, U.
    Finkel, R.
    Laskin, B.
    LaRosa, C.
    Amaral, S.
    Savant, J.
    Viteri, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S1121 - S1121
  • [22] A case report of a prolonged decrease in tacrolimus clearance due to co-administration of nirmatrelvir/ritonavir in a lung transplant recipient receiving itraconazole prophylaxis
    Tsuzawa, Ayumi
    Katada, Yoshiki
    Umemura, Keisuke
    Sugimoto, Mitsuhiro
    Nishikawa, Asami
    Sato, Yu-ki
    Yoshida, Yuko
    Kitada, Noriaki
    Yonezawa, Atsushi
    Nakajima, Daisuke
    Date, Hiroshi
    Terada, Tomohiro
    JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES, 2023, 9 (01)
  • [23] A case report of a prolonged decrease in tacrolimus clearance due to co-administration of nirmatrelvir/ritonavir in a lung transplant recipient receiving itraconazole prophylaxis
    Ayumi Tsuzawa
    Yoshiki Katada
    Keisuke Umemura
    Mitsuhiro Sugimoto
    Asami Nishikawa
    Yu-ki Sato
    Yuko Yoshida
    Noriaki Kitada
    Atsushi Yonezawa
    Daisuke Nakajima
    Hiroshi Date
    Tomohiro Terada
    Journal of Pharmaceutical Health Care and Sciences, 9
  • [24] Nirmatrelvir+ritonavir/tacrolimus interactionAcute kidney injury and off label use: case report
    Reactions Weekly, 2023, 1963 (1) : 417 - 417
  • [25] Nirmatrelvir/ritonavir Use With Tacrolimus in Lung Transplant Recipients: A Single-center Case Series
    Dewey, Katherine W. W.
    Yen, Bo
    Lazo, Jose
    Seijo, Leslie
    Jariwala, Ripal
    Shah, Rupal J. J.
    Quan, David
    Carpenter, Bethanne
    Singer, Jonathan Paul
    Breen, Karen
    Hays, Steven
    Florez, Rebecca
    TRANSPLANTATION, 2023, 107 (05) : 1200 - 1205
  • [26] A Case Report of Drug Interactions Between Nirmatrelvir/Ritonavir and Tacrolimus in a Patient With Systemic Lupus Erythematosus
    Yamamoto, Nanae
    Tsuchiya, Yuichi
    Fukuda, Mio
    Niiro, Hiroaki
    Hirota, Takeshi
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (01)
  • [27] Response to Comment on “Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin”
    Morganne Sindelar
    Daniel McCabe
    Elisabeth Carroll
    Journal of Medical Toxicology, 2023, 19 : 309 - 309
  • [28] Response to Comment on "Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin"
    Sindelar, Morganne
    McCabe, Daniel
    Carroll, Elisabeth
    JOURNAL OF MEDICAL TOXICOLOGY, 2023, 19 (03) : 309 - 309
  • [29] Single-center experience with nirmatrelvir/ritonavir in kidney transplant recipients on tacrolimus maintenance immunosuppression
    Mecadon, Krista
    Arvanitis, Panos
    Farmakiotis, Dimitrios
    Rogers, Ralph
    CLINICAL TRANSPLANTATION, 2022, 36 (08)
  • [30] Nirmatrelvir+ritonavir/tacrolimus interactionAcute kidney injury, neurotoxicity and drug overdose: case report
    Reactions Weekly, 2023, 1953 (1) : 321 - 321
12345